期刊文献+

盐酸贝那普利对IgA肾病尿蛋白的作用 被引量:2

下载PDF
导出
摘要 目的观察盐酸贝那普利对IgA肾病尿蛋白的疗效。方法 78例IgA肾病的患者随机分为两组:盐酸贝那普利组40例和对照组38例,治疗3个月,观察尿蛋白等指标及不良作用。结果 3个月后,两组尿蛋白下降差异有统计学意义(P<0.01),盐酸贝那普利疗效与不同肾脏病理类型亦有关,其中病理类型Ⅲ级疗效最差(P<0.05),轻中度尿蛋白降尿蛋白疗效显著高于重度尿蛋白(P<0.05)。结论盐酸贝那普利组降尿蛋白疗效明显高于对照组,加大ACEI剂量更能有效降低尿蛋白。
作者 毛茂津
出处 《中国现代药物应用》 2010年第24期140-141,共2页 Chinese Journal of Modern Drug Application
  • 相关文献

参考文献3

二级参考文献16

  • 1Remuzzi G, Bertani T. The pathophysiology of progressive nephropathies. N Engl J Med, 1998,339:1448-1456.
  • 2William JD, Coles GA. Proteinuria-a direct cause of renal morbidity? Kidney Int. 1994,45:443-450.
  • 3Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med, 1993,329:1456-1462.
  • 4Morelli E, Loon N, Meyer T,et al.Effects of converting-enzyme inhibition on barrier function in diabetic glomerulopathy. Diabetes, 1990,39:76- 82.
  • 5Lufft V, Kliem V, Hamkens A, et al. Antiproteinuric efficacy of fosinopril after renal transplantation is determined by the extent of vascular and tubulointerstitial damage. Clin Transplant, 1998, 12:409-415.
  • 6Rudberg S, Aperia A, Freyschuss U, et al. Enalapril reduces microalbuminuria in young normotensive type 1 (insulindependent) diabetic patients irrespective of its hypotensive effect. Diabetologia, 1990,33:470-476.
  • 7Ruggenenti P, Pema A, Gherardi G et al. Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet, 1999,354:359-364.
  • 8Ruggenenti P, Pema A, Mosconi L, et al. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinurine, non-diabetic nephropathy . Lancet, 1997, 394:1857-1863.
  • 9Peters H, Border WA, Noble NA. Targeting TGF-β overexpression in renal disease: maximizing the antifibrotic action of angiotensin Ⅱ blockade. Kidney Int, 1998,54:1570-1580.
  • 10Packer M, Poole-Wilson A, Armstrong PW, et al. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation, 1999,100:2312-2318.

共引文献44

同被引文献18

  • 1陈香美,郑法雷,陈仆,于阳,苏颖,汤力,魏日胞.盐酸巴尼地平治疗肾性高血压的前瞻性对照研究[J].中华肾脏病杂志,2004,20(3):169-172. 被引量:2
  • 2张宏.IgA肾病的分子遗传学研究[J].中华肾脏病杂志,2005,21(11):641-644. 被引量:12
  • 3Lai FM, Szeto CC, Choi PC, et al.Primary IGA nephropathy with low histologic grade and disease progression: is there a "point of no re- turn" [ J ].Am J Kidney Dis, 2000,39 : 104.
  • 4石晓云,陈香美,刘述文,等.血管转化酶抑制剂对IgA肾病的疗效及影响因素分析[J].中国内科杂志,2002,41(6):399-.403.
  • 5Nishimoto M,Fujita T.Renal mechanisms of salt-sensitive hypertension:contribution of two steroid receptor-associated pathways[J].Am J Physiol Renal Physiol,2015,308(5):F377-387.
  • 6Anderson AH,Yang W,Townsend RR,et al.Time-updated systolic blood pressure and the progression of chronic kidney disease:a cohort study[J].Ann Intern Med,2015,162(4):258-265.
  • 7Lee IT,Hung YJ,Chen JF,et al.Compartson of the efficacy and safety profiles of two fixed-dose combinations of antihypertensive agents,amlodipine/benazepril versus valsartan/hydrochlorothiazide,in patients with type 2 diabetes mellitus and hypertension:a 16-week,multicenter,randomized,double-blind,noninferiority study[J].Clin Ther,2012,34(8):1735-1750.
  • 8Lambert T,Blessberger H,Gammer V,et al.Effects of renal denervation on ambulatory blood pressure measurements in patients with resistant arterial hypertension[J].Clin Cardiol,2014,37(5):307-311.
  • 9Yang L,Yu J,Ma R,et al.The effect of combined antihypertensive treatment(felodipine with either irbesartan or metoprolol)on erectile function:a randomized controlled trial[J].Cardiology,2013,125(4):235-241.
  • 10Shaw RJ,Mc Duffie JR,Hendrix CC,et al.Effects of nurse-managed protocols in the outpatient management of adults with chronic conditions:a systematic review and meta-analysis[J].Ann Intern Med,2014,161(2):113-121.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部